Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
31.14
-1.03 (-3.20%)
May 13, 2025, 4:00 PM - Market closed
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $2.03 billion as of May 14, 2025. Its market cap has decreased by -0.90% in one year.
Market Cap
2.03B
Enterprise Value
1.34B
1-Year Change
-0.90%
Ranking
Category
Stock Price
$31.14
Market Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $2.03B, an increase of 143.00%. That is a compound annual growth rate of 20.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 2.09B | -19.60% |
| Dec 31, 2024 | 2.61B | 84.43% |
| Dec 29, 2023 | 1.41B | 3.16% |
| Dec 30, 2022 | 1.37B | -57.98% |
| Dec 31, 2021 | 3.26B | 18.59% |
| Dec 31, 2020 | 2.75B | 229.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.67B |
| Johnson & Johnson | 357.54B |
| AbbVie | 331.84B |
| Novo Nordisk | 292.03B |
| UnitedHealth Group | 290.19B |
| Abbott Laboratories | 225.73B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |